Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Amypore

    - PMLiVE

    Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities

    Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...

    Medscape Education

    - PMLiVE

    Lilly launches global Alzheimer’s campaign with Julianne Moore

    The new ‘Brain Health Matters’ campaign urges the public to prioritise brain health

    - PMLiVE

    AbbVie and ADARx enter multi-billion dollar partnership to develop siRNA therapies

    The companies will focus on developing therapeutics across neuroscience, immunology and oncology

    - PMLiVE

    J&J expands neuroscience capabilities with $14.6bn Intra-Cellular acquisition

    The deal gives the company access to a range of central nervous system disorder drugs

    - PMLiVE

    Novartis and Schrödinger to advance drug candidates in deal worth over $2.4bn

    The companies will advance therapeutics for undisclosed targets in Novartis’ core areas

    - PMLiVE

    AbbVie to expand neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition

    The deal includes a candidate in phase 1 development for Alzheimer's disease

    Bayer symbol

    Bayer and NextRNA Therapeutics enter oncology partnership worth $547m

    The companies will advance small molecule therapeutics against a new class of targets for cancer

    - PMLiVE

    Takeda and Degron enter molecular glue degrader partnership worth over $1.2bn

    The companies will focus on targets in oncology, neuroscience and inflammation

    - PMLiVE

    Novartis acquires DTx Pharma in deal worth up to $1bn

    The agreement gives Novartis access to three preclinical neuroscience programmes

    Applying Vibrotactile Stimulation to Improve Parkinson’s

    Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

    Impetus Digital

    Applying Vibrotactile Stimulation to Improve Parkinson’s

    Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

    Impetus Digital

    Cannes Lion 2022

    Our Top 5 Pharma Picks From Cannes Lions

    Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022.

    The Good Ideas Group

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links